Jackie Tohn Shares Her BRCA1 Journey and an Emotional Family Moment

A family story behind a public diagnosis

Jackie Tohn’s appearance on “The Jennifer Hudson Show” brought a personal story about inherited cancer risk into a warm family reunion. The “Nobody Wants This” actor discussed her BRCA1 diagnosis, then reassured her father that he shouldn’t blame himself for passing on the mutation. The exchange put two parts of the story side by side: the practical decisions that can follow a genetic finding, and the guilt a parent may feel when that finding runs through a family.

Tohn appeared with co-star Kristen Bell to discuss the show’s new season. Host Jennifer Hudson asked about Tohn’s parents, Alan and Bella, and her father’s experience with rare male breast cancer. Alan was diagnosed at 71 and later learned he carries a BRCA1 mutation, which he passed on to his daughter. Tohn has spoken publicly about her own BRCA1 diagnosis.

The family connection matters because an inherited mutation can turn one person’s diagnosis into information relevant to relatives, too. Alan’s experience led to the discovery of his BRCA1 status; for Tohn, that knowledge gave her a clearer picture of risk and a basis for discussing preventive care with her doctors. Genetic results can be difficult to absorb, but they can also help families ask more informed questions about their health history.

Risk, testing and preventive choices

She said the mutation gives her an estimated 85% chance of developing breast cancer and raises her risk of ovarian cancer. Tohn had a preventative double mastectomy last December and plans to have a hysterectomy this December. Those are substantial decisions, and her account makes clear that they followed information about her own risk rather than a diagnosis of cancer. The distinction is central to understanding why genetic testing can affect care before illness appears.

Her reason for discussing those choices on television was practical: she wants other people to consider genetic testing. She pointed to family histories involving rare cancers, cancer diagnosed at a young age, multiple cancer diagnoses in one person or family, and Ashkenazi Jewish ancestry. Tohn described her own test as a simple saliva sample. The sample may be straightforward to collect, but the result can raise difficult questions about relatives, future risk and what steps a person is prepared to take.

That’s where public accounts like Tohn’s can be useful, provided they’re understood as personal stories rather than instructions for everyone. Family history can prompt a conversation with a healthcare professional, while individual decisions depend on a person’s circumstances and medical guidance. If you’re working through a family history of cancer, the story’s clearest practical point is to ask what information is available and what it could mean for you.

A surprise visit from Alan and Bella

The discussion shifted when Hudson played a clip of Tohn’s parents chatting in their kitchen. Tohn became emotional as she talked about their support and imagined how thrilled they’d be to see themselves on TV. Hudson then called Alan and Bella onto the stage. The surprise changed the segment’s focus: a conversation about screening and risk became a direct exchange between a daughter and the father worried that he had caused her harm.

They spoke proudly about their daughter’s career and the person she has become. Alan also admitted he feels guilty about passing the BRCA1 mutation to her. Tohn responded with humor first, crediting her mother’s triangle playing for her own musical ability, then turned to the harder point: “You gave it all to me,” she said, referring to their talents and loving personalities. Now, she explained, she has information that let her take action, so her father doesn’t need to feel bad.

That reassurance doesn’t erase the medical consequences of an inherited mutation. It does, however, separate the fact of transmission from blame: Alan didn’t choose to pass on the mutation, and Tohn can use what she knows to make decisions about her health. This is more significant than it looks. The emotional burden of genetic information can extend beyond the person whose test result first brings it to light.

“Hell yeah!” Alan shouted.

Bell praised Tohn for choosing to find a way through frightening news rather than be consumed by it. Tohn’s account connects that attitude to a concrete benefit: sharing what she learned may prompt others to ask about their own family histories and testing options. She has also raised $125,000 for ovarian cancer research. Publicity can’t settle every question a family faces, but it can make a private subject easier to raise.

What the story may mean for other families

Tohn’s experience points to a broader role for family health information: it can help people recognize when a pattern deserves attention and start a conversation about testing. And yet, awareness is only a beginning. A genetic result can bring uncertainty alongside useful information, and a person may need time and professional support to decide what to do with it.

(And this is the part most people overlook.) The family conversation doesn’t end when someone receives a result; relatives may have their own questions, feelings and choices. Tohn’s exchange with Alan shows how those conversations can involve love and guilt at the same time. No tidy resolution.

For Tohn, the takeaway is that knowing about inherited risk gave her choices. By speaking openly about her medical decisions and inviting others to consider testing, she turns a family’s difficult discovery into information that may help someone else act sooner. Her story doesn’t prescribe a single path. It shows why asking about family history can be a meaningful first step.

ADVERTISEMENT